Alternaturals, Inc. (ANAS)
| Market Cap | 2.07M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -381.30K |
| Shares Out | 104.25M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 43,396 |
| Open | 0.0199 |
| Previous Close | 0.0199 |
| Day's Range | 0.0199 - 0.0199 |
| 52-Week Range | 0.0055 - 0.0210 |
| Beta | -6.70 |
| RSI | 58.15 |
| Earnings Date | n/a |
About Alternaturals
Alternaturals, Inc. manufactures and distributes supplements and all-natural remedies that are alternatives to prescription drugs. Its products include Focamine, an all-natural focus, attention, and concentration promoter for people suffering from ADHD; and Sombium, an alternative sleep aid. The company was formerly known as Zhong Nong Yuan Fang Holdings, Inc. and changed its name to Alternaturals, Inc. in March 2022. Alternaturals, Inc. was incorporated in 1995 and is based in Reno, Nevada. [Read more]
Financial Performance
In 2000, Alternaturals's revenue was $18,000, a decrease of -90.86% compared to the previous year's $197,040. Losses were -$306,837, -9.04% less than in 1999.
News
Alternaturals, Inc. Signs New Agri-Tech Cooperation Agreement
RENO, NV / ACCESSWIRE / September 28, 2022 / Alternaturals, Inc. (OTC PINK:ANAS) signed a strategic cooperation agreement with Shianyi (Beijing) Digital Technology Co., Ltd. Under this agreement, the...